| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |